Germ-line genetic testing for a panel of cancer-susceptibility genes is recommended in all epithelial ovarian cancer cases [13], but it is not always available in clinical practice, and, in some cases, it is limited to BRCA1/2. Here, BRCA1 is linked to ovarian carcinoma.